Home › Compare › ELYS vs DGRO

ELYS vs DGRO: Dividend Comparison 2026

ELYS yields 2000000.00% · DGRO yields 2.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ELYS wins by $4.879226400974806e+39M in total portfolio value
10 years
ELYS
ELYS
● Live price
2000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.879226400974806e+39M
Annual income
$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00
Full ELYS calculator →
DGRO
iShares Core Dividend Growth ETF
● Live price
2.10%
Share price
$70.18
Annual div
$1.47
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.6K
Annual income
$235.38
Full DGRO calculator →

Portfolio growth — ELYS vs DGRO

📍 ELYS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodELYSDGRO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ELYS + DGRO cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
ELYS pays
DGRO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ELYS
Annual income on $10K today (after 15% tax)
$170,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr
DGRO
Annual income on $10K today (after 15% tax)
$178.14/yr
After 10yr DRIP, annual income (after tax)
$200.07/yr
At 15% tax rate, ELYS beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ELYS + DGRO for your $10,000?

ELYS: 50%DGRO: 50%
100% DGRO50/50100% ELYS
Portfolio after 10yr
$2.439613200487403e+39M
Annual income
$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ELYS right now

ELYS
Analyst Ratings
2
Buy
Consensus: Buy
Price Target
$1.75
+1749900.0% upside vs current
Range: $1.00 — $2.50
Altman Z
-5.8
Piotroski
3/9
DGRO
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ELYS buys
0
DGRO buys
0
No recent congressional trades found for ELYS or DGRO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricELYSDGRO
Forward yield2000000.00% ✓2.10%
Annual dividend / share$2.00 ✓$1.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$4.879226400974806e+39M$31.6K ✓
Annual income after 10y$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00 ✓$235.38
Total dividends collected$4.879195005460081e+39M ✓$2.2K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: ELYS vs DGRO ($10,000, DRIP)

YearELYS PortfolioELYS Income/yrDGRO PortfolioDGRO Income/yrGap
1← crossover$200,010,700$200,000,000.00$11,290$209.57+$200.00M → ELYS
2$3,738,731,768,458$3,738,517,757,009.35$12,722$213.54+$3738731.76M → ELYS
3$65,315,062,866,930,490$65,311,062,423,938,240.00$14,314$217.18+$65315062866.92M → ELYS
4$1,066,400,830,062,625,000,000$1,066,330,942,945,357,500,000.00$16,080$220.53+$1066400830062625.00M → ELYS
5$16,272,182,796,453,826,000,000,000$16,271,041,747,565,660,000,000,000.00$18,040$223.59+$16272182796453826560.00M → ELYS
6$232,054,240,113,661,900,000,000,000,000$232,036,828,878,069,680,000,000,000,000.00$20,215$226.40+$2.3205424011366188e+23M → ELYS
7$3,092,799,066,104,688,500,000,000,000,000,000$3,092,550,768,067,767,400,000,000,000,000,000.00$22,627$228.96+$3.0927990661046884e+27M → ELYS
8$38,524,105,697,352,694,000,000,000,000,000,000,000$38,520,796,402,351,967,000,000,000,000,000,000,000.00$25,302$231.31+$3.8524105697352695e+31M → ELYS
9$448,468,826,014,798,700,000,000,000,000,000,000,000,000$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00$28,268$233.44+$4.484688260147987e+35M → ELYS
10$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$31,557$235.38+$4.879226400974806e+39M → ELYS

ELYS vs DGRO: Complete Analysis 2026

ELYS — Stock

Elys BMG Group, Inc. engages in the provision of business-to-consumer gaming services in the United States and Europe. The company offers betting platform software services to leisure betting establishments; and operates web based and land-based leisure betting establishments. Its gaming product offerings include sports betting; and online casino, such as online slot and table games, poker, bingo, skilled and interactive games, virtual sports betting, and horse racing. It provides its products through physical, land-based retail locations; newgioco.it or commercial webskins linked to its website; and mobile devices. The company was formerly known as Elys Game Technology, Corp. and changed its name to Elys BMG Group, Inc. in January 2024. Elys BMG Group, Inc. was incorporated in 1998 and is based in Toronto, Canada.

Full ELYS Calculator →

DGRO — ETF

The iShares Core Dividend Growth ETF seeks to track the investment results of an index composed of U.S. equities with a history of consistently growing dividends.

Full DGRO Calculator →
📬

Get this ELYS vs DGRO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ELYS vs SCHDELYS vs JEPIELYS vs OELYS vs KOELYS vs MAINELYS vs VIGELYS vs NOBLELYS vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.